Published in Hospital Law Weekly, February 2nd, 2006
1. Vioxx withdrawal from the market, which prompted U.S. Food and Drug Administration (FDA) reforms and legal battles.
2. Medicare Part D, for which final regulations released and enrollment began, for with the large coverage gap has provoked widespread criticism that the plan does not sufficiently achieve its goals of expanding available drug coverage to Medicare beneficiaries, many of whom have large prescription drug bills and will need to fund much of the cost of their...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2006-02-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.